Preclinical development of CAT-354, an IL-13 neutralizing...

British Journal of Pharmacology 2012 Vol. 166; Iss. 1

Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma

RD May, PD Monk, ES Cohen, D Manuel, F Dempsey, NHE Davis, AJ Dodd, DJ Corkill, J Woods, C Joberty-Candotti, LA Conroy, F Koentgen, EC Martin, R Wilson, N Brennan, J Powell, IK Anderson
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
166
Year:
2012
Language:
english
Pages:
17
DOI:
10.1111/j.1476-5381.2011.01659.x
File:
PDF, 1.88 MB
english, 2012
Conversion to is in progress
Conversion to is failed